TY  - GEN
AU  - Fillon,Mike
TI  - Immune checkpoint inhibitors are superior to docetaxel as second-line therapy for patients with non-small cell lung carcinoma
SN  - 1542-4863
PY  - 2019///0509
KW  - Carcinoma, Non-Small-Cell Lung
KW  - Docetaxel
KW  - Humans
KW  - Lung Neoplasms
N1  - Publication Type: Journal Article; Comment
UR  - https://doi.org/10.3322/caac.21423
ER  -